Risk prediction models for melanoma: A systematic review

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 8, 2014, Pages 1450-1463

  Usher Smith, Juliet A ^a   Emery, Jon ^a,b,c   Kassianos, Angelos P ^a   Walter, Fiona M ^a,b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN;

CANCER RISK; DYSPLASTIC NEVUS; EPILUMINESCENCE MICROSCOPY; GENOTYPE; HAIR COLOR; HUMAN; LENTIGO; MELANOMA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN COLOR; SUN EXPOSURE; SUNBURN; SYSTEMATIC REVIEW; AREA UNDER THE CURVE; RECEIVER OPERATING CHARACTERISTIC; RISK; SKIN NEOPLASMS; STATISTICAL MODEL;

AREA UNDER CURVE; HUMANS; MELANOMA; MODELS, STATISTICAL; RISK; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SKIN NEOPLASMS;

EID: 84905454857     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0295     Document Type: Review

References (57)

1. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001;93:678-83.
2. De Vries E, Coebergh J-WW. Melanoma incidence has risen in Europe. BMJ 2005;331:698.
3. Coory M, Baade P, Aitken J, Smithers M, McLeod G R C, Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control 2006;17:21-7.
4. Downing A, Yu XQ, Newton-Bishop J, Forman D. Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003. Int J Cancer 2008;123:861-6.
5. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol 2009;129:1666-74.
6. Balch CM, Gershenwald JE, Soong S-J, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009;27:6199-206.
7. Waldmann A, Nolte S, Weinstock MA, Breitbart EW, Eisemann N, Geller AC, et al. Skin cancer screening participation and impact on melanoma incidence in Germany-an observational study on incidence trends in regions with and without population-based screening. Br J Cancer 2012;106:970-4.
8. Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 2012;66:201-11.
9. Wolff T, Tai E, Miller T. Screening for skin cancer: an update of the evidence for the U. S. Preventive Services Task Force. Ann Intern Med 2009;150:194-8.
10. Freedberg KA, Geller AC, Miller DR, Lew RA, Koh HK. Screening for malignant melanoma: a cost-effectiveness analysis. J Am Acad Dermatol 1999;41:738-45.
11. Losina E, Walensky RP, Geller A, Beddingfield FC, Wolf LL, Gilchrest BA, et al. Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol 2007;143:21-8.
12. Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice. East Melbourne: 8th ed. 2012.
13. Masri GD, Clark WH, Guerry D, Halpern A, Thompson CJ, Elder DE. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 1990;22:1042-8.
14. Wolfe JT. The role of screening in the management of skin cancer. Curr Opin Oncol 1999;11:123-8.
15. Eiser JR, Pendry L, Greaves CJ, Melia J, Harland C, Moss S, et al. Is targeted early detection for melanoma feasible? Self assessments of risk and attitudes to screening. J Med Screen 2000;7:199-202.
16. Nielsen K, Masback A, Olsson H, Ingvar C. A prospective, populationbasedstudyof 40000womenregardinghost factors, UVexposureand sunbed use in relation to risk and anatomic site of cutaneous melanoma. Pigment Cell Melanoma Res 2011;24:1071.
17. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988;124:869-71.
18. Marrett LD, King WD, Walter SD, From L. Use of host factors to identify people at high risk for cutaneous malignant melanoma. CMAJ 1992;147:445-53.
19. Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making 1993;13:313-21.
20. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993;12:1293-316.
21. Mar. V, Wolfe R, Kelly JW. Predicting melanoma risk for the Australian population. Australas J Dermatol 2011;52:109-16.
22. Glanz K, Schoenfeld E, Weinstock MA, Layi G, Kidd J, Shigaki DM. Development and reliability of a brief skin cancer risk assessment tool. Cancer Detect Prev 2003;27:311-5.
23. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Zanetti R, Masini C, et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005;41:2040-59.
24. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005;41:45-60.
25. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005;41:28-44.
26. Barbini P, Cevenini G, Rubegni P, Massai MR, Flori ML, Carli P, et al. Instrumental measurement of skin colour and skin type as risk factors for melanoma: a statistical classification procedure. Melanoma Res 1998;8:439-47.
27. Dwyer T, Stankovich JM, Blizzard L, Fitz Gerald LM, Dickinson JL, Reilly A, et al. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? Am J Epidemiol 2004;159:826-33.
28. Cho E, Rosner BA, Feskanich D, Colditz GA. Risk factors and individual probabilities of melanoma for whites. J Clin Oncol 2005;23:2669-75.
29. Guther S, Ramrath K, Dyall-Smith D, Landthaler M, Stolz W. Development of a targeted risk-group model for skin cancer screening based on more than 100, 000 total skin examinations. J Eur Acad Dermatol Venereol 2011;26:86-94.
30. Bakos L, Mastroeni S, Bonamigo RR, Melchi F, Pasquini P, Fortes C. A melanoma risk score in a Brazilian population. An Bras Dermatol 2013;88:226-32.
31. Quereux G, Moyse D, Lequeux Y, Jumbou O, Brocard A, Antonioli D, et al. Development of an individual score for melanoma risk. Eur J Cancer Prev 2011;20:217-24.
32. Goldberg MS, Doucette JT, Lim HW, Spencer J, Carucci JA, Rigel DS. Risk factors for presumptive melanoma in skin cancer screening: American Academy of Dermatology National Melanoma/Skin Cancer Screening Program experience 2001-2005. J Am Acad Dermatol 2007;57:60-6.
33. Fortes C, Mastroeni S, Bakos L, Antonelli G, Alessandroni L, Pilla MA, et al. Identifying individuals at high risk of melanoma: a simple tool. Pigment Cell Melanoma Res 2010;19:393-400.
34. Williams LH, Shors AR, Barlow WE, Solomon C, White E. Identifying persons at highest risk of melanoma using self-assessed risk factors. J Clin Exp Dermatol Res 2011;2.pii:1000129.
35. English DR, Armstrong BK. Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia. Br Med J (Clin Res Ed) 1988;296:1285-8.
36. Amir E, Freedman OC, Seruga B, Evans DG. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 2010;102:680-91.
37. Win AK, Macinnis RJ, Hopper JL, Jenkins MA. Risk prediction models for colorectal cancer: a review. Cancer Epidemiol Biomarkers Prev 2012;21:398-410.
38. Farber MJ, Heilman ER, Friedman RJ. Dysplastic nevi. Dermatol Clin 2012;30:389-404.
39. Harbauer A, Binder M, Pehamberger H, Wolff K, Kittler H. Validity of an unsupervised self-administered questionnaire for self-assessment of melanoma risk. Melanoma Res 2003;13:537-42.
40. Ford D, Bliss JM, Swerdlow AJ, Armstrong BK, Franceschi S, Green A, et al. Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE). Int J Cancer 1995;62:377-81.
41. Wilson JM, Jungner YG. Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 1968;65:281-393.
42. Beddingfield F. Melanoma: a decision analysis to estimate the effectiveness and cost-effectiveness of screening and an analysis of the relevant epidemiology of the disease [dissertation]. Santa Monica, CA: RAND Graduate School; 2002.
43. Girgis A, Clarke P, Burton RC, Sanson-Fisher RW. Screening for melanoma by primary health care physicians: a cost-effectiveness analysis. J Med Screen 1996;3:47-53.
44. Newton Bishop JA, Bishop DT. The genetics of susceptibility to cutaneous melanoma. Drugs Today 2005;41:193-203.
45. Marzuka-Alcala A, Gabree MJ, Tsao H. Melanoma susceptibility genes and risk assessment. Methods Mol Biol 2014;1102:381-93.
46. Augustsson A. Melanocytc naevi, melanoma and sun exposure. Acta Derm Venereol Suppl (Stockh) 1991;166:1-34.
47. Fears TR, Guerry D, Pfeiffer RM, Sagebiel RW, Elder DE, Halpern A, et al. Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol 2006;24:3590-6.
48. Garbe C, Kruger S, Stadler R, Guggenmoos-Holzmann I, Orfanos CE. Markers and relative risk in a German population for developing malignant melanoma. Int J Dermatol 1989;28:517-23.
49. Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994;102:695-9.
50. Landi MT, Baccarelli A, Calista D, Pesatori A, Fears T, Tucker M, et al. Combined riskfactors for melanoma in a Mediterranean population. Br J Cancer 2001;85:1304-10.
51. Mackie R M, Freudenberger T, Aitchison T C. Personal risk-factor chart for cutaneous melanoma. Lancet 1989;2:487-90.
52. Weiss J, Garbe C, Bertz J, Biltz H, Burg G, Hennes B, et al. Risk factors for the development of malignant melanoma in West Germany. results of a multicenter-case control study. Hautarzt 1990;41:309-13.
53. Zaridze DG, Mukeriia AF, Basieva TK, Shlenskaia IN, Bukin IV. The role of endogenous and exogenous factors in the etiology of skin melanoma. Vopr Onkol 1992;38:141-7.
54. Jackson A, Wilkinson C, Ranger M, Pill R, August P. Can primary prevention or selective screening for melanoma be more precisely targeted through general practice? A prospective study to validate a self administered risk score. BMJ 1998;316:34-8.
55. Westerdahl J, Anderson H, Olsson H, Ingvar C. Reproducibility of a self-administered questionnaire for assessment of melanoma risk. Int J Epidemiol 1996;25:245-51.
56. Quereux G, Nguyen J-M, Volteau C, Lequeux Y, Dreno B. Creation and test of a questionnaire for self-assessment of melanoma risk factors. Eur J Cancer Prev 2010;19:48-54.
57. Quereux G, Nguyen J-M, Cary M, Jumbou O, Lequeux Y, Dreno B. Validation of the self-assessment of melanoma risk score for a melanoma-targeted screening. Eur J Cancer Prev 2012;21:588-95.